New CRISPR Phase 1 trial hints at a first-of-its-kind heart treatment on horizon A gene therapy targeting ANTIGPTL3 reduced cholesterol and triglyceride levels simultaneously.

https://www.drugdiscoverynews.com/new-crispr-phase-1-trial-hints-at-a-first-of-its-kind-heart-treatment-on-horizon-16804